DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Sean McCarthy will participate on a panel at the BIO International Convention in San Diego, CA titled “New Models for External Innovation by Pharma”
News | 06. 17. 2008
